Utility of PCD Diagnostics to Improve Clinical Care

Recruiting Observational Study
Primary Ciliary Dyskinesia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
2 and older
Sex
Any
Study type
Observational
Participants needed
50 (estimated)
Sponsor
Connecticut Children's Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This cross-sectional and longitudinal observational study is to gather data on the utility of tests that are used to make a diagnosis of primary ciliary dyskinesia (PCD). There is new testing available, called nasal nitric oxide testing, that non-invasively measures nitric oxide levels in the sinus cavity. Individuals with PCD characteristically have low levels, but this testing does not have exte…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥ 2 years of age * Must have two of the following clinical history points: * Neonatal respiratory distress * Chronic nasal congestion/runny nose * Chronic cough * Situs/laterality defects * Bronchiectasis * Ability to provide informed consent or consent of parent/guardian …
Contacts

Melanie S Collins, MD

860-545-9440

mcollin@connecticutchildrens.org

CONTACT

Sigrid M Almeida, BS

8608375343

salmeida@connecticutchildrens.org

CONTACT